Navigation Links
Lollipop Breast Reduction Technique Reduces Recovery Time

BEVERLY HILLS, Calif., Dec. 23, 2013 /PRNewswire-iReach/ -- Dr. Applebaum's innovative minimal incision breast reduction technique, or lollipop breast reduction is designed to help patients suffering from neck and back pain as a result of large breasts. Benefits of the minimal incision breast reduction include minimal recovery time and scarring, and this procedure is oftentimes covered by a patient's insurance plan. 

Breast Reduction Surgery

Large breasts can cause significant neck and back pain for many women. Our Beverly Hills breast reduction surgery is a safe, permanent option for women who suffer from large, pendulous breasts. In the reduction mammoplasty procedure, a surgeon removes excess fat, skin and tissue from the breasts to achieve a natural, proportional breast size and look.

About the Lollipop Breast Reduction

With over twenty years of experience, Beverly Hills plastic surgeon Dr. Robert Applebaum has mastered the French technique, or minimal incision breast reduction. Dr. Applebaum prefers this breast reduction technique because it requires fewer incisions and results in only one small scar from the nipple down to the breast fold. Another benefit of the lollipop technique is that it allows for the shortest recovery time, with no dressings, bindings or draining.

Breast Reduction Surgery May Be Covered by Insurance

In many cases breast reduction is medically necessary and may be covered by a patient's health insurance. Consult with Dr. Applebaum's office to see if you can take advantage of your already met insurance deductible before the end of the year when scheduling this surgery.

About Dr. Robert Applebaum

Dr. Applebaum is a board-certified plastic surgeon with a Beverly Hills practice and over twenty years of experience performing surgical and non-invasive procedures including breast reductions, tummy tucks, facelifts, and laser treatments. He is a world-renowned surgeon, lecturer and educator who uses the latest and best procedures and technology to serve his international clientele

To learn more about Dr. Applebaum's breast reduction expertise and to see before and after breast reduction galleries, visit or contact or call 310.956.4305. 

Media Contact: Robert Applebaum, Breast Reduction Beverly Hills, 310-956-4305,

News distributed by PR Newswire iReach:

SOURCE Breast Reduction Beverly Hills
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Ventana receives FDA clearance for Estrogen Receptor (ER) Image Analysis and Digital Read Application for breast cancer
2. Monoclonal Antibodies Market in Breast Cancer to 2019
3. Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
4. Associates for Breast and Prostate Cancer Studies Honors Ann-Margret, Robert Wagner and Bill and Roseann Patterson at 24th Annual The Talk of the Town Gala
5. Edith Sanford Breast Cancer Partners with Athena Breast Health Network to Personalize Breast Cancer Risk Assessment
6. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
7. Computer-Aided Image Analysis Aims to Offer ‘Second Opinion’ in Breast Tumor Diagnosis
8. UE LifeSciences Launches Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries
9. Polaris Group Files New IND for ADI-PEG 20 in Breast Cancer
10. ResearchMoz: Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
11. Tennessee Breast Center Selects Sectra RIS/PACS
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... developing DCVax® personalized immune therapies for solid tumor cancers, ... an additional independent director, and the Company welcomes ... allegations in a recent anonymous internet report on NW ... initiatives. Linda Powers stated, "We agree ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... Technical Program that includes over 2,000 technical presentations offered in symposia, oral ... chemistry and applied spectroscopy, covers a wide range of applications such as, but ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
Breaking Biology News(10 mins):